Special Issue "Cell Cycle Deregulation in Cancers"


A special issue of Cancers (ISSN 2072-6694).

Deadline for manuscript submissions: closed (15 October 2013)

Special Issue Editor

Guest Editor
Dr. Rebecca S. Hartley
Department of Cell Biology and Physiology; MSC08-4750; University of New Mexico; Albuquerque, NM 87131, USA
Website: http://hsc.unm.edu/som/cbp/hartley.shtml
E-Mail: rhartley@salud.unm.edu
Interests: cell cycle; cyclins; cyclin/CDKs; post-transcriptional control of gene expression; RNA binding proteins; microRNAs; cell cycle deregulation in cancer; developmental basis of cancer; microenvironmental control of the cell cycle

Special Issue Information

Dear Colleagues,

Loss of normal cell cycle control is a hallmark of cancer, resulting in targeting of cell cycle regulators for cancer therapy. In general, strategies used to exploit the deregulated cancer cell cycle by directly targeting cell cycle regulators do not provide cancer specificity. This issue of Cancers invites contributions of original research reports, clinical studies, and review articles that focus on cancer specific modifications that would allow indirect targeting of cell cycle deregulation. Potential topics include modifications of the microenvironment, inflammatory signaling, stress response, and post-transcriptional events that result in cell cycle deregulation.

Dr. Rebecca S. Hartley
Guest Editor


Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. Papers will be published continuously (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are refereed through a peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed Open Access quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 800 CHF (Swiss Francs).


  • cell cycle regulators
  • cell cycle deregulation
  • cancer cell cycle
  • cancer specific modifications
  • cancer vulnerabilities
  • cancer therapy
  • tumor microenvironment
  • inflammatory signaling
  • stress response
  • post-transcription

Published Papers (3 papers)

by ,  and
Cancers 2014, 6(1), 79-111; doi:10.3390/cancers6010079
Received: 14 November 2013; in revised form: 24 December 2013 / Accepted: 3 January 2014 / Published: 13 January 2014
Show/Hide Abstract | PDF Full-text (1655 KB) | HTML Full-text | XML Full-text

by , , , , ,  and
Cancers 2014, 6(1), 28-41; doi:10.3390/cancers6010028
Received: 17 October 2013; in revised form: 25 November 2013 / Accepted: 26 November 2013 / Published: 19 December 2013
Show/Hide Abstract | PDF Full-text (602 KB) | HTML Full-text | XML Full-text

by ,  and
Cancers 2013, 5(4), 1655-1675; doi:10.3390/cancers5041655
Received: 16 October 2013; in revised form: 12 November 2013 / Accepted: 20 November 2013 / Published: 4 December 2013
Show/Hide Abstract | Cited by 1 | PDF Full-text (631 KB) | HTML Full-text | XML Full-text

Last update: 13 May 2013

Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert